Bioatla Correlations

BCAB
 Stock
  

USD 3.94  0.13  3.41%   

The correlation of Bioatla is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioatla moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioatla moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Continue to Trending Equities.
  
The ability to find closely correlated positions to Bioatla could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioatla when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioatla - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioatla to buy it.

Moving together with Bioatla

0.72BLUBellus Health Earnings Call  TomorrowPairCorr
0.82BBIOBridgebio PharmaPairCorr
0.87MBRXMoleculin Biotech Earnings Call  This WeekPairCorr
0.78FOLDAmicus Therapeutics Upward RallyPairCorr
0.85BCRXBiocryst Pharma Normal TradingPairCorr
0.74BCTXBriaCell Therapeutics Fiscal Year End 27th of October 2022 PairCorr
0.66BCYCBicycle Therapeutics PlcPairCorr
0.7MDNAMedicenna TherapeuticsPairCorr

Moving against Bioatla

0.68BBIBrickell BiotechPairCorr
0.59CUECue BiopharmaPairCorr
0.56BCLIBrainstorm Cell Earnings Call  This WeekPairCorr

Related Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
FUBER
FMSFT
UBERMSFT
AMSFT
AF
XOMJPM
  
High negative correlations   
MRKTWTR
TF
TUBER
MRKF
MRKUBER
TTWTR

Bioatla Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Bioatla stock performing well and Bioatla company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Bioatla's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
TWTR 2.32 (0.16)  0.00 (0.23)  0.00 (0.0465)  0.00  4.00 (5.55)  17.65 
MSFT 1.75  0.05  0.02  0.02  2.28  0.0179 (1.79)  2.97 (4.24)  7.83 
UBER 3.74  0.26  0.05  0.15  4.76  0.05 (3.67)  6.40 (7.19)  16.91 
F 2.63  0.15  0.04  0.06  3.16  0.0408 (2.84)  5.27 (5.54)  16.83 
T 1.15 (0.04)  0.00 (0.08)  0.00 (0.0233)  0.00  2.20 (2.45)  10.81 
A 1.93  0.17  0.07  0.12  2.26  0.07 (2.10)  4.22 (3.29)  9.78 
CRM 2.58  0.17  0.05  0.08  3.11  0.0473 (2.73)  5.77 (5.16)  16.84 
JPM 1.46 (0.05)  0.00 (0.06)  0.00 (0.0288)  0.00  3.31 (2.51)  10.79 
MRK 0.98  0.02  0.02  0.04  1.24  0.0246 (0.97)  1.83 (2.50)  6.96 
XOM 2.10  0.06  0.02  0.05  2.98  0.0228 (1.93)  3.97 (4.21)  11.86 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bioatla without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fund Screener Now

   

Fund Screener

Find actively-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module

Invested in Bioatla?

You need to understand the risk of investing before taking a position in Bioatla. The danger of trading Bioatla is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bioatla is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bioatla. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bioatla is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Bioatla information on this page should be used as a complementary analysis to other Bioatla's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Bioatla Stock analysis

When running Bioatla price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Is Bioatla's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioatla. If investors know Bioatla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioatla listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
147.4 M
Quarterly Revenue Growth YOY
0.32
Return On Assets
-0.28
Return On Equity
-0.52
The market value of Bioatla is measured differently than its book value, which is the value of Bioatla that is recorded on the company's balance sheet. Investors also form their own opinion of Bioatla's value that differs from its market value or its book value, called intrinsic value, which is Bioatla's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioatla's market value can be influenced by many factors that don't directly affect Bioatla's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioatla's value and its price as these two are different measures arrived at by different means. Investors typically determine Bioatla value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioatla's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.